OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts. (May 2022) - Offersen, B.; Alsner, J.; Nielsen, H.M.; Bechmann, T.; Nielsen, M.H.; Mjaaland, I.; Kamby, C.; Krkove, C.; Lorincz, T.; Al-Rawi, S.; Stoere, E.B.; Schreiber, A.; et al.